@WHO: Newer antiviral drugs, immunomodulators and anti-SARS COV-2 monoclonal antibodies are now being considered for evaluation for new #COVID19 treatment options. 👉 https://t.co/g5vWTbi29c https://t.co/miFNfoD4UX

http://twitter.com/WHO
via IFTTT